Literature DB >> 10051654

Continuous axenic cultivation of Pneumocystis carinii.

S Merali1, U Frevert, J H Williams, K Chin, R Bryan, A B Clarkson.   

Abstract

Continuous axenic culture of Pneumocystis carinii has been achieved. A culture vessel is used that allows for frequent medium exchange without disturbance of organisms that grow attached to a collagen-coated porous membrane. The growth medium is based on Minimal Essential Medium with Earle's salt supplemented with S-adenosyl-L-methionine, putrescine, ferric pyrophosphate, N-acetyl glucosamine, putrescine, p-aminobenzoic acid, L-cysteine and L-glutamine, and horse serum. Incubation is in room air at 31 degrees C. The pH of the medium begins at 8.8 and rises to approximately 9 as the cells grow. Doubling times calculated from growth curves obtained from cultures inoculated at moderate densities ranged from 35 to 65 hours. With a low-density inoculum, the doubling time is reduced to 19 hours. The morphology of cultured organisms in stained smears and in transmission electron micrographs is that of P. carinii, and P. carinii-specific mAbs label the cultured material. Cultured organisms are infective for immunosuppressed rats and can be stored frozen and used to reinitiate culture.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10051654      PMCID: PMC26796          DOI: 10.1073/pnas.96.5.2402

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  27 in total

1.  Ornithine decarboxylase in Pneumocystis carinii and implications for therapy.

Authors:  M Sarić; A B Clarkson
Journal:  Antimicrob Agents Chemother       Date:  1994-11       Impact factor: 5.191

2.  Close association of Pneumocystis carinii from infected rat lung with culture cells as shown by light and electron microscopy.

Authors:  M S Bartlett; M P Goheen; C H Lee; M M Shaw; M M Durkin; J W Smith
Journal:  Parasitol Res       Date:  1994       Impact factor: 2.289

3.  In vitro attachment of Pneumocystis carinii from mouse and rat origin.

Authors:  E M Aliouat; E Dei-Cas; A Ouaissi; F Palluault; B Soulez; D Camus
Journal:  Biol Cell       Date:  1993       Impact factor: 4.458

Review 4.  The challenge of Pneumocystis carinii culture.

Authors:  E Sloand; B Laughon; M Armstrong; M S Bartlett; W Blumenfeld; M Cushion; A Kalica; J A Kovacs; W Martin; E Pitt
Journal:  J Eukaryot Microbiol       Date:  1993 Mar-Apr       Impact factor: 3.346

5.  Murine Pneumocystis carinii adherence to vertical monolayers of cultured mink lung cells (MiCl1).

Authors:  R E Garner; A N Walker; M N Horst
Journal:  J Clin Microbiol       Date:  1992-09       Impact factor: 5.948

6.  Proliferation of rat Pneumocystis carinii on cells sheeted on microcarrier beads in spinner flasks.

Authors:  C H Lee; N L Bauer; M M Shaw; M M Durkin; M S Bartlett; S F Queener; J W Smith
Journal:  J Clin Microbiol       Date:  1993-06       Impact factor: 5.948

7.  Use of an ATP bioluminescent assay to evaluate viability of Pneumocystis carinii from rats.

Authors:  F Chen; M T Cushion
Journal:  J Clin Microbiol       Date:  1994-11       Impact factor: 5.948

8.  A randomized trial of three antipneumocystis agents in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical Trials Group.

Authors:  S A Bozzette; D M Finkelstein; S A Spector; P Frame; W G Powderly; W He; L Phillips; D Craven; C van der Horst; J Feinberg
Journal:  N Engl J Med       Date:  1995-03-16       Impact factor: 91.245

9.  Clinically achievable plasma deferoxamine concentrations are therapeutic in a rat model of Pneumocystis carinii pneumonia.

Authors:  S Merali; K Chin; L Del Angel; R W Grady; M Armstrong; A B Clarkson
Journal:  Antimicrob Agents Chemother       Date:  1995-09       Impact factor: 5.191

10.  Attachment of Pneumocystis carinii to primary cultures of rat alveolar epithelial cells.

Authors:  S T Pottratz; A L Weir
Journal:  Exp Cell Res       Date:  1995-12       Impact factor: 3.905

View more
  27 in total

Review 1.  Genetics of surface antigen expression in Pneumocystis carinii.

Authors:  J R Stringer; S P Keely
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

Review 2.  Pneumocystis.

Authors:  Francis Gigliotti; Andrew H Limper; Terry Wright
Journal:  Cold Spring Harb Perspect Med       Date:  2014-11-03       Impact factor: 6.915

Review 3.  Update on the diagnosis and treatment of Pneumocystis pneumonia.

Authors:  Eva M Carmona; Andrew H Limper
Journal:  Ther Adv Respir Dis       Date:  2010-08-24       Impact factor: 4.031

4.  Effect of a bis-benzyl polyamine analogue on Pneumocystis carinii.

Authors:  S Merali; M Saric; K Chin; A B Clarkson
Journal:  Antimicrob Agents Chemother       Date:  2000-02       Impact factor: 5.191

5.  Gene arrays at Pneumocystis carinii telomeres.

Authors:  Scott P Keely; Hubert Renauld; Ann E Wakefield; Melanie T Cushion; A George Smulian; Nigel Fosker; Audrey Fraser; David Harris; Lee Murphy; Claire Price; Michael A Quail; Kathy Seeger; Sarah Sharp; Carolyn J Tindal; Tim Warren; Eduard Zuiderwijk; Barclay G Barrell; James R Stringer; Neil Hall
Journal:  Genetics       Date:  2005-06-18       Impact factor: 4.562

6.  Therapeutic efficacies of GW471552 and GW471558, two new azasordarin derivatives, against pneumocystosis in two immunosuppressed-rat models.

Authors:  Elena Jimenez; Antonio Martínez; El Moukhtar Aliouat; Jesus Caballero; Eduardo Dei-Cas; Domingo Gargallo-Viola
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

7.  Pneumocystis carinii exhibits a conserved meiotic control pathway.

Authors:  Joshua W Burgess; Theodore J Kottom; Andrew H Limper
Journal:  Infect Immun       Date:  2007-11-05       Impact factor: 3.441

8.  Biofilm formation by Pneumocystis spp.

Authors:  Melanie T Cushion; Margaret S Collins; Michael J Linke
Journal:  Eukaryot Cell       Date:  2008-09-26

9.  Development of a rapid real-time PCR assay for quantitation of Pneumocystis carinii f. sp. carinii.

Authors:  Hans Henrik Larsen; Joseph A Kovacs; Frida Stock; Vibeke H Vestereng; Bettina Lundgren; Steven H Fischer; Vee J Gill
Journal:  J Clin Microbiol       Date:  2002-08       Impact factor: 5.948

Review 10.  A new name (Pneumocystis jiroveci) for Pneumocystis from humans.

Authors:  James R Stringer; Charles B Beard; Robert F Miller; Ann E Wakefield
Journal:  Emerg Infect Dis       Date:  2002-09       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.